We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BMY. Bristol-Myers Squibb Company (BMY)'s share was trading at $59.01 as of March 16th. BMY’s trailing and forward P/E were 22.79 and 8.73 respectively according to Yahoo Finance.
[caption id="attachment_1229650" align="aligncenter" width="768"]Bristol-Myers Squibb (BMY) presents a compelling yet high-stakes investment opportunity as...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.